ArticleJACC. Case reports2025
Severe Diffuse Takayasu Arteritis Manifestation in Childhood.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTakayasu arteritis (TA) is a large-vessel vasculitis that primarily affects the aorta and the pulmonary and coronary arteries. CASE SUMMARY: A 4-year-old boy was diagnosed in 2022 with pyoderma gangrenosum (PG) and required prolonged multidisciplinary care, including aggressive medical immunosuppression for severe skin lesions. In October 2024, after a period of clinical stability, he presented with a seizure and right-sided weakness. Head and neck computed tomography angiography revealed features of acute inflammatory vasculitis. These findings along with clinical criteria led to a diagnosis of TA. Vascular imaging (echocardiogram, computed tomography, magnetic resonance imaging) showed diffuse disease affecting the aortic root, aortic arch, proximal supra-aortic vessels, proximal descending aorta, and proximal left pulmonary artery. The patient's immunomodulatory treatment was switched to a combination of corticosteroids, cyclophosphamide, and antiplatelet therapy, with ongoing careful multidisciplinary clinical surveillance and assessment of treatment efficacy. DISCUSSION: This case highlights the rare coexistence of PG and childhood TA, with only 10 cases reported in the literature. Despite extensive immunosuppressive treatment for PG, the patient exhibited severe, diffuse vasculitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.